Parkinson’s UK chosen as Anderson Strathern’s new charity of the year

  • News

09 April 2019

Parkinson’s UK has been chosen by our people as the Anderson Strathern new charity of the year, we  supported SAMH last year raising over £9,000.00 for them.

Each year our Corporate Social Responsibility Committee opens the employee-led selection process to choose a new charity, Parkinson’s UK was chosen as our charitable focal point for the year ahead and our staff will be organising and taking part in activities throughout the year to raise money for Parkinson’s.

Parkinson's is a progressive neurological condition affecting more than 145,000 people in the UK. Parkinson's UK is the UK's leading charity supporting those with the condition. Its mission is to find a cure and improve life for everyone affected by Parkinson's through cutting edge research, information, support and campaigning.

Jane Rutherford, Head of the Corporate Social Responsibility Committee said:

“After such a successful year working with SAMH, our team is delighted to be supporting Parkinson’s UK this year. We’re incredibly excited about the prospect of raising funds for Parkinson’s UK as it is now the second most common neurodegenerative disorder in the UK.

Over the next 12 months, we will organise and take part in a number of activities and events to raise awareness of the amazing work Parkinson’s UK undertakes to help those affected by Parkinson’s disease.

As part of our overall corporate social responsibility activities, every employee is given a day and a half’s paid leave to take part in CSR-related activities, so I’m looking forward to seeing how they will be using this entitlement.”

Emma Hall, East Scotland Regional Fundraiser for Parkinson’s UK, said:

“We are delighted that Anderson Strathern has chosen Parkinson’s UK for its charity partner this year. I’m really looking forward to working with the law firm to help better the life of people affected with Parkinson’s.

It’s only through partnerships like this and the generosity of individuals that Parkinson’s UK can continue to fund world-leading research toward a cure for Parkinson’s and also deliver the local services that so many people living with the condition rely on.”